Mounjaro maker launches High Court action to block counterfeit drug sites

US pharma giant Eli Lilly has launched legal action in the London High Court to block black-market websites selling fake versions of its medicine. Eli Lilly, the pharma giant behind the weight-loss drug Mounjaro, instructed American legal heavyweights Kirkland Ellis to file a case in the English High Court, which appeared in the public system on Thursday. The group holds various trademarks, registered with the UK Intellectual Property Office, to protect its brands, pharmaceutical products, and related services. The case names BT, EE, Plusnet, Sky, TalkTalk and Virgin Media as defendants. A spokesperson for Lilly told City AM: Lilly is taking action to block black-market websites selling fake versions of Lilly’s medicines. What is being sold on these websites is not a medicine – it is entirely unverified, unauthorised, and not worth the risk. Regulators and law enforcement worldwide have warned of the potentially serious risks of fake medicines. We will continue work